Your browser doesn't support javascript.
loading
Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
Kaplan, Ihsan; Can, Canan; Kepenek, Ferat; Ibiloglu, Ibrahim; Güzel, Yunus.
Afiliación
  • Kaplan I; From the Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, University of Health Sciences.
  • Can C; From the Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, University of Health Sciences.
  • Kepenek F; From the Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, University of Health Sciences.
  • Ibiloglu I; Department of Pathology, Dicle University Medical School, Diyarbakir, Turkey.
  • Güzel Y; From the Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, University of Health Sciences.
Clin Nucl Med ; 48(6): e307-e309, 2023 Jun 01.
Article en En | MEDLINE | ID: mdl-36754357
ABSTRACT: 18 F-FDG PET/CT was performed to evaluate the response to treatment in a 62-year-old female patient who was operated for adrenocortical carcinoma. High FDG uptake was observed in recurrent lesion in the left adrenal gland site and metastatic lesions. In the 68 Ga-FAPI-04 PET/CT study, low FAPI uptake was observed in both recurrences and metastases. In this case, we demonstrated the superiority of 18 F-FDG PET/CT over 68 Ga-FAPI-04 PET/CT in the evaluation of adrenocortical carcinoma.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Corteza Suprarrenal / Carcinoma Corticosuprarrenal Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Nucl Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Corteza Suprarrenal / Carcinoma Corticosuprarrenal Límite: Female / Humans / Middle aged Idioma: En Revista: Clin Nucl Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos